876 related articles for article (PubMed ID: 23225501)
1. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
[TBL] [Abstract][Full Text] [Related]
2. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
3. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
Dane C; Batmaz G; Dane B; Cetin A
Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
[TBL] [Abstract][Full Text] [Related]
4. Non-16/18 high-risk HPV infection predicts disease persistence and progression in women with an initial interpretation of LSIL.
Lyons YA; Kamat AA; Zhou H; Mody DR; Schwartz MR; Hobday C; Ge Y
Cancer Cytopathol; 2015 Jul; 123(7):435-42. PubMed ID: 25903015
[TBL] [Abstract][Full Text] [Related]
5. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
[TBL] [Abstract][Full Text] [Related]
6. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Castle PE; Solomon D; Schiffman M; Wheeler CM
J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
Castle PE; Schiffman M; Wheeler CM; Wentzensen N; Gravitt PE
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1675-81. PubMed ID: 20615885
[TBL] [Abstract][Full Text] [Related]
9. Genotyping of human papillomavirus in triaging of low-grade cervical cytology.
Söderlund-Strand A; Eklund C; Kemetli L; Grillner L; Törnberg S; Dillner J; Dillner L
Am J Obstet Gynecol; 2011 Aug; 205(2):145.e1-6. PubMed ID: 21658668
[TBL] [Abstract][Full Text] [Related]
10. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.
Castle PE; Glass AG; Rush BB; Scott DR; Wentzensen N; Gage JC; Buckland J; Rydzak G; Lorincz AT; Wacholder S
J Clin Oncol; 2012 Sep; 30(25):3044-50. PubMed ID: 22851570
[TBL] [Abstract][Full Text] [Related]
11. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
[TBL] [Abstract][Full Text] [Related]
12. Difference Between Cryotherapy and Follow Up Low Grade Squamous Lesion of Cervix Uteri.
Jahic M; Jahic E; Mulavdic M; Hadzimehmedovic A
Med Arch; 2017 Aug; 71(4):280-283. PubMed ID: 28974850
[TBL] [Abstract][Full Text] [Related]
13. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
14. Low-grade squamous intraepithelial lesion on Papanicolaou test: follow-up rates and stratification of risk for high-grade squamous intraepithelial lesion.
Rufail M; Lew M; Pang J; Jing X; Heider A; Cantley RL
J Am Soc Cytopathol; 2020; 9(4):258-265. PubMed ID: 32402830
[TBL] [Abstract][Full Text] [Related]
15. Does the interval between papanicolaou tests influence the quality of cytology?
Jeronimo J; Khan MJ; Schiffman M; Solomon D;
Cancer; 2005 Jun; 105(3):133-8. PubMed ID: 15822121
[TBL] [Abstract][Full Text] [Related]
16. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.
Castle PE; Shaber R; LaMere BJ; Kinney W; Fetterma B; Poitras N; Lorey T; Schiffman M; Dunne A; Ostolaza JM; McKinney S; Burk RD
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):946-53. PubMed ID: 21415357
[TBL] [Abstract][Full Text] [Related]
18. Analytical performance of cervista HPV 16/18 in SurePath pap specimens.
Guo M; Khanna A; Feng J; Patel S; Zhang W; Gong Y; Huo L; Staerkel G
Diagn Cytopathol; 2015 Apr; 43(4):301-6. PubMed ID: 25352375
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
[TBL] [Abstract][Full Text] [Related]
20. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
